Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Implementation of substance use screening in rural federally-qualified health center clinics identified high rates of unhealthy alcohol and cannabis use among adult primary care patientsAddiction science & clinical practice, 2023-09, Vol.18 (1), p.56-56, Article 56 [Peer Reviewed Journal]2023. Evans Medical Foundation, Inc. and BioMed Central Ltd. ;COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Evans Medical Foundation, Inc. and BioMed Central Ltd. 2023 ;ISSN: 1940-0640 ;ISSN: 1940-0632 ;EISSN: 1940-0640 ;DOI: 10.1186/s13722-023-00404-y ;PMID: 37726839Full text available |
|
2 |
Material Type: Article
|
Time-lagged association between counseling and/or 12-Step attendance with subsequent opioid use in a secondary analysis from a randomized, clinical trial of medications for opioid use disorderDrug and alcohol dependence reports, 2022-12, Vol.5, p.100100, Article 100100 [Peer Reviewed Journal]2022 The Authors ;ISSN: 2772-7246 ;EISSN: 2772-7246 ;DOI: 10.1016/j.dadr.2022.100100 ;PMID: 36644220Full text available |
|
3 |
Material Type: Article
|
Changes in the diagnosis of congenital cardiovascular malformations during the 1st year of life: impacts on epidemiological risk factor associationsCardiology in the young, 2017-05, Vol.27 (4), p.770-781 [Peer Reviewed Journal]Cambridge University Press 2016 ;ISSN: 1047-9511 ;EISSN: 1467-1107 ;DOI: 10.1017/S104795111600130X ;PMID: 28462756Full text available |
|
4 |
Material Type: Article
|
Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trialThe Lancet (British edition), 2018-01, Vol.391 (10118), p.309-318 [Peer Reviewed Journal]2018 Elsevier Ltd ;Copyright © 2018 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jan 27, 2018 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(17)32812-X ;PMID: 29150198Full text available |
|
5 |
Material Type: Article
|
SCORE2 Report 13: Intraretinal Hemorrhage Changes in Eyes With Central or Hemiretinal Vein Occlusion Managed With Aflibercept, Bevacizumab or Observation. Secondary Analysis of the SCORE and SCORE2 Clinical TrialsAmerican journal of ophthalmology, 2021-02, Vol.222, p.185-193 [Peer Reviewed Journal]2020 Elsevier Inc. ;Copyright © 2020 Elsevier Inc. All rights reserved. ;2020. Elsevier Inc. ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2020.08.030 ;PMID: 32828880Full text available |
|
6 |
Material Type: Article
|
Patient-Reported Visual Function Outcomes After Anti–Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal or Hemiretinal Vein Occlusion: Preplanned Secondary Analysis of a Randomized Clinical TrialArchives of ophthalmology (1960), 2019-08, Vol.137 (8), p.932 [Peer Reviewed Journal]Copyright American Medical Association Aug 2019 ;ISSN: 2168-6165 ;EISSN: 1538-3601 ;DOI: 10.1001/jamaophthalmol.2019.1519Full text available |